Biofilm-associated infection due to Staphylococcus epidermidis, the leading nosocomial pathogen, is a major problem for the public health system, but the regulation of this important phenotype is not completely understood. Using a highly discriminatory screening procedure for genes that influence biofilm formation, we identified the transcriptional regulator SarZ as a novel important determinant of biofilm formation and biofilm-associated infection, on the basis of the significant impact of sarZ on the transcription of the biosynthetic operon for biofilm exopolysaccharide. In addition, sarZ influenced the expression of a series of virulence genes, including genes that influence the expression of lipases and proteases, resistance to an important human antimicrobial peptide, and hemolysis. Our study indicates that the SarZ regulator has a key role in maintaining the typical S. epidermidis phenotype, which is characterized by pronounced biofilm formation and immune evasion, a likely reason for the success of S. epidermidis as a colonizing organism and pathogen in chronic, biofilm-associated infection.
Staphylococcus epidermidis is the most important member of the coagulase-negative staphylococci, which are normal microflora on the human skin and mucous membranes that have attracted considerable attention more recently as dangerous nosocomial pathogens [1] . There are increasingly frequent reports about the devastating complications of indwelling medical devicerelated infections due to S. epidermidis, which prolong disease and result in higher morbidity and mortality, especially among immunocompromised patients [2] . In particular, S. epidermidis plays an important role in foreign body-related infections, such as catheter-related infections, prosthetic-valve-related endocarditis, prosthetic joint-related infections, and peritoneal dialysis-related infections [1, 3] . The repertoire of virulence factors in S. epidermidis is relatively limited, especially compared with the more virulent S. aureus [4] . In contrast, biofilm formation has long been recognized as a key virulence determinant for S. epidermidis [1, 5] . Bacteria in a biofilm are more resistant to attacks by innate host defense mechanisms and antibiotics; this increased resistance is based on the specific biofilm structure and metabolism [6, 7] .
Several genes are directly or indirectly involved in the molecular mechanisms of biofilm formation in S. epidermidis, including fbe, atlE, aap, and the ica locus [8 -11] . Undoubtedly the most important gene product involved in the accumulation phase of biofilm formation is the polysaccharide intercellular adhesin (PIA), the biosynthetic machinery of which is encoded by the ica locus [9] . PIA is a biofilm exopolysaccharide that surrounds the cells in a typical biofilm matrix and has an additional function in providing protection from antibacterial peptides and phagocytosis [12] .
Biofilms represent the common mode of growth for many bacteria, including S. epidermidis, particularly under the environmental conditions found on the human skin [13] . Accordingly, there are numerous regulatory mechanisms by which S. epidermidis responds to environmental stimuli and coordinates the expression of biofilm structural factors and biofilm-specific metabolism [14, 15] . However, we are far from understanding the intricate details of this regulation. Several regulators have been found to impact biofilm formation by controlling the expression of biofilm factors, mostly PIA [16 -23] .
Many biofilm-related structural and regulatory genes have been discovered by transposon mutagenesis and subsequent in vitro screening for biofilm formation. A previous study that screened for biofilm determinants in S. epidermidis was particularly successful in that regard [24] . Since then, many researchers have tried to use similar methods to detect additional biofilm determinants, but due to the fact that biofilm formation is strongly dependent on the specific model system, many falsepositive clones are usually found. To overcome this problem, we aimed to discover key biofilm determinants of S. epidermidis using a highly discriminatory screening procedure with 2 different, consecutive in vitro assays. By use of this procedure, we identified only 1 gene, sarZ, whose pivotal regulatory role in S. epidermidis biofilm formation and virulence we describe in the present article.
METHODS
Bacterial strains, plasmids, and growth conditions. Escherichia coli was grown in Luria-Bertani medium, and S. epidermidis strain 1457 [25] was grown in tryptic soy broth (TSB) (Oxoid). When necessary, media were supplemented with ampicillin (100 g/mL for E. coli), erythromycin (2.5 g/mL for selection of Tn917-positive organisms) or chloramphenicol (20 g/mL for pQG plasmids in staphylococci). For microarray experiments, cultures grown overnight were diluted 1:100 into 50 mL of TSB and incubated at 37°C with shaking at 180 rpm until grown to the late exponential growth phase.
DNA manipulations. Staphylococcal chromosomal DNA was extracted as described elsewhere [26] . Plasmids were prepared by use of standard protocols, except for modifications for staphylococci described elsewhere [21] , and introduced by electroporation [27] . ExTaq Polymerase was obtained from Takara, restriction enzymes from New England Biolabs, and oligonucleotides from Invitrogen or Sigma.
Transposon mutagenesis and identification of insertion loci. Transposon mutagenesis was performed using plasmid pTV1ts, which contains transposon Tn917, as described elsewhere [28] . The presence of the erythromycin cassette was used in Southern blot analysis to confirm single transposon insertion. The probe used for Southern hybridization was a 500-bp polymerase chain reaction (PCR) product of the erythromycin cassette (obtained with primers ermB5 [5'-CGAAATTGGAACAGGTAAAG-3'] and ermB3 ). Adaptor PCR [29] was used to identify the insertion locus. Adaptors carrying HindIII and AccI restriction sites were ligated to HindIII-cleaved fragments of S. epidermidis genomic DNA. Fragments were amplified for subsequent DNA sequencing by use of the purified ligation product as the template for the first PCR and the diluted product of the first PCR as the template of a sequential PCR (primers: adaptor1 Complementation of the sarZ mutant. The chloramphenicol resistance cassette (cat) from plasmid pBT1 [30] was amplified by PCR with primers Cat5 (5'-CGGAAGCTTAAGCTTCAAA-CGAAAATTGGATAAAGTGG-3') and Cat3 (5'-CGGGGA-TCCTTATAAAAGCCAGTCATTAGGCC-3'), cut with HindIII and BamHI, and ligated into the HindIII and BamHI cleaved vector pYJ90 (containing origins of replication from both pUC19 and pE194 [31] ). The resulting plasmid pQG31 was transformed into S. epidermidis as negative control. The sarZ gene including a 500-bp sequence upstream of sarZ was amplified by PCR from the genomic DNA of S. epidermidis strain 1457 with primers SarZ5 (5'-CGCG-GATCCTCCATGAGCTTTCGCTGTAA-3') and SarZ3 (5'-CCG-GAATTCTCGCTATTGCTAAATTGAAAGT-3'), introducing BamHI/EcoRI restriction sites. The 1-kb sarZ fragment was ligated into BamHI/ EcoRI digested pQG31, which resulted in plasmid pQGsarZ.
Semiquantitative biofilm assay. Semiquantitative biofilm assays were performed as described elsewhere [21, 23] . Subsequently, cells were either directly stained with safranin or fixed by Bouin's fixative. The fixative was removed after 1 h and wells were washed with PBS. Organisms in the wells were then stained with crystal violet, and the floating stain was washed off with slowly running water. After drying, the stained biofilm was read with a MicroELISA autoreader (BioRad) at 570 nm (crystal violet stain) or 490 nm (safranin stain).
Primary attachment assay. A method described elsewhere [21] was used, with slight modifications. S. epidermidis strains were grown to the early stationary phase, and cell suspensions were adjusted with TSB to a 600-nm optical density (OD 600 ) of 1.0. The diluted cultures were pipetted into 96-well tissue culture plates and incubated at 37°C for 1 h. The subsequent procedures are the same as those used for the semiquantitative biofilm assay.
Immunoblot analysis of PIA production. PIA was isolated and detected by immuno-dot blots as described [21] . The degree of immunoreactivity was measured and quantitated with a photodetection system (Quantity One 4.6; BioRad).
Quantitative reverse-transcription (RT) PCR. Oligonucleotide primers and probes were designed using Primer Express. Quantitative RT-PCR was performed as described [26] . The experiments were performed in triplicate, with 16S ribosomal RNA as a control. Microarray experiments. RNA isolation, DNA removal, reaction cleanup, cDNA synthesis and hybridization, and estimation of labeling efficiency were performed as described elsewhere [26] . Biotinylated S. epidermidis cDNA was hybridized to custom Affymetrix GeneChips (RMLChip 3) with 98.8% coverage of genes from RP62A [32] (2465 probe sets of 2494 open reading frames) and scanned in accordance with standard GeneChip protocols (Affymetrix). Each experiment was replicated at least 3 times. Affymetrix GeneChip Operating Software (GCOS, version 1.4) was used to perform the preliminary analysis of the custom chips at the probe-set level. Subsequent data analysis was performed as described elsewhere [26] . To be included in the final gene list, gene expression had to have been changed at least 2-fold for 1 of the treatments. The complete set of microarray data was deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GEO, available at http://www.ncbi.nlm.nih.gov/geo/) and is accessible through GEO Series accession number GSE8523.
Confocal laser scanning microscopy. S. epidermidis was inoculated from precultures grown overnight at a dilution of 1:100 with TSB that contained 0.5% glucose in 8-well polystyrene chambers (Lab-Tek II; Nunc). After 24 h of incubation at 37°C without shaking, supernatants were gently removed, and biofilm [32] ) and insertion loci of the 2 transposon mutants. The mutant with the insertion locus at 1996632 bp was selected for further investigation. B, Semiquantitative biofilm assay in microtiter plates performed with fixation and crystal violet staining. ***P Ͻ .001; sarZ vs. wild-type strain; sarZ (pQGsarZ), vs. sarZ (pQG31). Data are means Ϯ standard error of the mean of 4 independent experiments. C, Confocal laser scanning microscopy of static biofilm formation. Biofilms were stained with propidium iodide. OD 570 , optical density 570 nm.
layers were washed and resuspended in 400 L of saline. Biofilm formation was made visible by staining cells with 4 mol/L propidium iodide (Sigma) for 10 min. Images were acquired on a Zeiss LSM 5 Pascal laser-scanning confocal unit with an Axiovert 100 microscope with a 63 ϫ 1.4-NA oil-immersion objective. Zeiss 3D software (Image VisArt) was used for the 3-dimensional visualization of biofilm structures.
Protease assay. Protease activity was determined by an agar plate assay. The test agar contained 1.0% skim milk and 1.0% agar. Cultures were grown at 37°C for 10 h and 15 mL of culture filtrate were then lyophilized. The lyophilysates were dissolved in 3 mL of 20 mmol/L Tris-HCl containing 1 mmol/L CaCl 2 (pH, 7.8) and passed through 0.22-mm pore filters. Next, 50 L were loaded into holes in the plates, which were incubated at 37°C for 8 h.
Killing assays. S. epidermidis cells were grown to exponential growth phase (OD 600 , 2.5-3.0), harvested, washed twice with 10 mmol/L sodium phosphate buffer (pH, 6.5) that included 100 mmol/L NaCl, and resuspended in the same buffer. The cells were diluted to a final concentration of 10 6 cells in each sample, exposed to a range of concentrations of the human antimicrobial peptide human ␤-defensin 3 (hBD3), and incubated at 37°C for 3 h. Appropriate dilution series of the samples were spread on TSB agar plates and incubated at 37°C for 24 h for colony counting. hBD3 was synthesized by the Peptide Synthesis Unit, Research Technology Branch, National Institute of Allergy and Infectious Diseases.
Rat model of central venous catheter-related infection. The rat model of central venous catheter (CVC)-related infection was as described elsewhere [23] . In brief, healthy male Sprague-Dawley rats (weight, 500 g) (Academia Sinica) were surgically dissected, and silastic lumen-within-lumen catheters (inside diameter, 0.12 mm) were inserted into their right external jugular veins. Twenty-four hours after CVC placement, 1 ϫ 10 6 cfu of S. epidermidis were inoculated into the catheters. The catheters were flushed with heparin every day. The rats were sacrificed on day 8 and the bacteria recovered from hearts, livers, kidneys, blood, and catheters were counted. All animal work was approved by the ethics committee of Fudan University.
Mouse model of subcutaneous foreign body infection. A murine model of subcutaneous foreign body infection like that NOTE. The entire list of differentially expressed genes can be found on the National Center for Biotechnology Information Gene Expression Omnibus (GEO, available at http://www.ncbi.nlm.nih.gov/geo/) and is accessible through GEO Series accession number GSE8523.
described by Kadurugamuwa et al. [33] was used, with slight modifications. In brief, eighteen male BALB/c mice (weight 20 g) (Academia Sinica); were randomly and evenly divided into 2 groups and treated with S. epidermidis strain 1457 and S. epidermidis sarZ mutant strain, respectively. One-centimeter long silicon catheters (14 gauge) were implanted subcutaneously on each side at the flank of each mouse before injection of 10 7 cfu to the catheter bed. After 10 days, the mice were sacrificed. Catheters were aseptically removed and manipulated by use of the method described elsewhere [33] , except that we used a sonication time of 30 min. Then serial dilutions of the wash fluid were plated on TSB plates and the recovered S. epidermidis colonies were counted.
RESULTS
Transposon mutagenesis identified sarZ as key biofilm determinant. To detect novel genes that influenced biofilm formation and biofilm-associated infection due to S. epidermidis, Tn917 transposon mutagenesis was performed in the clinical isolate S. epidermidis 1457. In contrast to previous, similar approaches, a large number of clones (ϳ20,000) were tested to account for the insertion bias of Tn917 [34] . Furthermore, clones were screened by use of 2 consecutive, different in vitro tests to discover genes that showed a consistent influence on biofilm formation. The 20,000 clones were first assayed by biofilm formation in round-bottom Greiner microtiter plates and subsequent staining with safranin without fixation, as described elsewhere [21] . About 100 clones were found that were then screened using Costar (Corning) plates with fixation and crystal violet staining. Surprisingly, this consecutive, exclusive method yielded only 2 clones that were deficient in biofilm formation, both of which had a single Tn917 insertion at 2 different locations in the sarZ (SERP1979) gene ( figure 1A ). This gene shares 79% identity and 91% similarity in amino acid sequence with the virulence regulator gene sarZ of S. aureus [35] . Both have a helixturn-helix multiple antibiotic resistance protein motif characteristic of the SarA protein family in staphylococci [36] . To confirm that sarZ was involved in biofilm formation, a single transposon mutant was selected for further studies and complemented with a plasmid expressing sarZ, which resulted in restored biofilm formation (figure 1B). Of note, growth of the mutant strain was indistinguishable from that of the wild-type strain (data not shown). Finally, 3-dimensional biofilm formation was monitored by use of confocal laser-scanning microscopy, which confirmed that sarZ had a strong impact on biofilm development ( figure 1C ). These findings indicated that sarZ is a key determinant of biofilm formation in S. epidermidis.
SarZ influences primary attachment and exopolysaccharidedependent biofilm accumulation. Biofilm formation is a 2-step process that involves initial attachment to a surface and subsequent accumulation due to proliferation and cell-cell adhesion [5] . Primary attachment assays demonstrated that the first step of biofilm formation is controlled by sarZ ( figure 2A) . Further, immunoblot analysis of polysaccharide intercellular adhesin (PIA), the main factor influencing biofilm accumulation in S. epidermidis strain 1457, showed that sarZ also has an impact on the second step of biofilm formation (figure 2B). Thus, sarZ has a profound influence on both the initial and accumulative phases of biofilm development, which is due at least in part to the regulation of PIA production.
The sarZ regulon comprises a specific set of S. epidermidis virulence genes. The Sar family of DNA-binding proteins are transcriptional regulators with a frequently global influence on gene expression, notably including the expression of virulence genes [36] . To investigate whether sarZ plays a similar role in S. epidermidis, we determined the sarZ regulon by genome-wide analysis of gene expression using S. epidermidis Affymetrix gene chips (RMLchip3). Interestingly, whereas the sarZ regulon comprised ϳ80 genes, the most dramatic regulatory effects occurred in genes that were implicated in virulence (table 1) . Of note, all genes of the ica operon for PIA biosynthesis and 3 different S. epidermidis protease genes-sspA, sspB, and sspC-showed strong up-regulation by sarZ. Further, 3 lipase genes were regulated by sarZ, but in an inconsistent manner. Finally, 3 genes in close proximity to the sarZ gene, 2 that coded for hypothetical genes and 1 that coded for a quinone reductase, were strongly down-regulated by sarZ. Quantitative RT-PCR of the icaB gene in the ica operon, 1 of the down-regulated lipase genes (SERP0018), the sspB protease gene, and the strongly repressed quinone reductase gene, confirmed the data obtained with the microarray and demonstrated that the observed increased expression of PIA was caused by up-regulation of the transcription of PIA biosynthetic genes ( figure 3 ). In addition, we used quantitative RT-PCR to determine expression of RNAIII, the regula- a Data are the number of animals from which bacteria were recovered/total number of animals. b The no. of bacteria found in each organ or site tested (heart, liver, kidney, blood, and catheter) and the total infection rate (in all organs tested) were analyzed by the Fisher exact test. NS, not significant (P Ͼ .05).
tory molecule of the staphylococcal agr system [37] , because the SarA regulator and some other Sar paralogs are known to have a strong regulatory influence on agr expression [38] . However, we did not detect significant differences in RNAIII expression between the wild-type and sarZ mutant strains, which demonstrated that sarZ does not influence agr expression in S. epidermidis.
SarZ controls proteolytic and hemolytic activity. The virulence of S. epidermidis is largely defined by its ability to evade host defenses [4, 39] . One mechanism it uses to subvert a key part of innate host defense is the proteolytic degradation of antimicrobial peptides, which play a crucial role in controlling bacterial colonization on epithelia and contribute to the killing of bacteria in the neutrophil phagosome after infection. Proteolytic activity was significantly decreased in the sarZ mutant strain and restored in the complemented strain (figure 4A), indicating that sarZ has an impact on protease secretion, an established virulence factor for S. epidermidis. To test whether the sarZdependent up-regulation of S. epidermidis proteases resulted in decreased degradation of antimicrobial peptides, we determined susceptibility to the important epithelial human antimicrobial peptide hBD3 [40] . We found that there was a slight, yet significant, increase in susceptibility to hBD3 for the sarZ mutant strain (figure 4B), indicating that sarZ-dependent gene regulation had an impact on the immune evasion properties of S. epidermidis.
The secretion of hemolytic toxins is an important determinant of staphylococcal virulence. Among the sarZ downregulated genes, we detected 1 gene whose expression was increased ϳ2-3-fold in the sarZ mutant. This gene had similarities to hemolysins, such as the S. lugdunensis slush peptides [41] and the gononococcal growth inhibitor peptide AGS of S. haemolyticus [42] . Interestingly, the sarZ mutant exhibited pronounced ␤ hemolysis on sheep agar plates, a phenotype known from the synergistic activities of ␦-toxin and either ␣-or ␤-toxin in S. aureus [43] , but not commonly seen in S. epidermidis ( figure  4C ), which indicates that sarZ regulates hemolysis, possibly by an effect on the gene SERP2258.
SarZ is an important determinant of S. epidermidis biofilm-associated infection. Biofilm-associated infection on implants is the main type of infection caused by S. epidermidis [1] . To assess whether sarZ impacts the virulence of S. epidermidis during this type of infection, we used 2 different animal models: a CVC-related infection model in rats and a subcutaneous foreign material infection-related model in mice. In the CVC model, the rats were inoculated with 1 ϫ 10 6 cfu of wild-type or mutant strains through the catheters 24 h after surgery. The bacteria recovered from the organs, blood, and catheters were counted after sacrificing rats on the day 8 of infection. Although the specific infection rates of the single organs and catheters did not show statistically significant differences, the overall infection rate was significantly different between the rats infected with the S. epidermidis strain 1457 wild-type and sarZ mutant strains (P ϭ .014, Fisher exact test) (table 2). In the subcutaneous murine catheter infection model (which involved infection with 1 ϫ 10 7 cfu), we detected a significant difference in the amount of bacteria recovered from the infected catheters of mice inoculated with the wild-type strain and mice inoculated with the sarZ mutant strains (P ϭ .006, Mann-Whitney test) (figure 5). Thus, both animal models indicated that sarZ contributes significantly to the development of biofilm-associated infection due to S. epidermidis.
DISCUSSION
S. epidermidis is the most frequent cause of foreign body-related infections, in which the formation of biofilms plays a preeminent role. However, the development of an S. epidermidis biofilm and the regulation of biofilm expression in this important opportunistic pathogen are not fully understood. Using a transposon mutagenesis approach with a 2-step screening procedure, we identified the SarA paralog SarZ of S. epidermidis as a key factor that influences biofilm formation. The Sar family of transcriptional regulators comprises at least 12 paralogs in S. aureus, including SarA, SarR, SarS, SarU, SarX, SarV, Rot, and MgrA, which interact in a complicated regulatory network [36] . Many of these paralogs affect the expression of S. aureus virulence genes, such as the regulation of protease and surface protein expression. In addition, the Rot protein has a pivotal function as a mediator of quorum-sensing regulation in S. aureus [44, 45] . Finally, several Sar paralogs have been implicated in the control of biofilm formation. SarA regulates the expression of genes in the ica locus directly, by binding to the ica promoter [20, 46] . In addition, SarA and some other Sar paralogs may influence biofilm formation indirectly, by regulating the quorum-sensing system agr, which has been implicated in regulating biofilm formation via the control of surfactant-like peptides [7, 47] . In S. epidermidis, there are several Sar paralogs, but only the SarA protein has been characterized in more detail [48] . Similar to its role in S. aureus, SarA in S. epidermidis controls biofilm formation [20] .
Recently, one role of S. aureus SarZ in controlling virulence has been described [35] . This Sar paralog has 53% similarity in amino acid sequence to SarA of S. aureus. Interestingly, SarZ of S. epidermidis is very similar to its homolog in S. aureus, although with no significant similarity with S. epidermidis SarA has been detected. In silkworm and mouse infection models, an S. aureus sarZ mutant strain exhibited less virulence than the wild-type strain [35] . In our study, sarZ deficiency resulted in decreased virulence in infections typical of S. epidermidis, indicating that this regulator plays a key role in staphylococcal virulence.
While S. aureus SarZ has been reported to influence hemolytic activity in a positive way by up-regulation of ␣-hemolysin production [35] , results from our study indicate a contrasting influence of S. epidermidis SarZ on hemolytic activity. As S. epidermidis is not commonly hemolytic, the finding that S. epidermidis has the means to cause hemolysis, which may be mediated in part by the not yet further characterized sarZ-regulated SERP2258 gene, is of great interest. One may only speculate as to why hemolytic factors are not normally produced in S. epidermidis, although they might have considerable potential as virulence factors. As a possible explanation, it has been suggested that the expression of virulence genes to the degree found in virulent S. aureus is counterproductive for S. epidermidis colonization and transmission [49] . Therefore, S. epidermidis as a species has evolved to suppress the acquisition and expression of determinants that cause significant harm to the human host.
There are indications that staphylococci produce colonization factors and acute virulence factors, such as toxins and exoenzymes, at different times during infection, or during different modes of existence; they produce different factors during the initial infection period, compared with the later infection period, and during infection, compared with colonization [22, 50] . Accordingly, there are global regulators that control the switch between these modes, most notably the quorum-sensing regulator agr, which suppresses the production of colonization factors and promotes secretion of acute virulence factors [37] . Similarly, the sarZ regulator up-regulates genes involved in biofilm formation and colonization, and it appears to have an additional role in suppressing hemolytic factors. It will be an important part of future research to identify conditions under which sarZ is repressed, possibly to allow for the development of a more acute phase during S. epidermidis pathogenesis.
